stars 1 stars 2 stars 3

BiOptic. Inc, is a Biotechnology Instrument company that develops, manufactures, and markets fully-integrated systems and tests for Fluorescence Immunoassay analysis in the research, clinical and industrial markets. The Company's systems enable rapid, sophisticated Antibody-Antigen interaction testing by automating otherwise complex manual laboratory procedures. BiOptic's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation and detection, which enable the analysis of complex biological samples in its proprietary pen-size gel-cartridges. Through its strong protein chemistry capabilities, the Company is focusing on those applications in the research, pharmaceutical, clinical market; food, agricultural, and environmental testing.

BiOptic, Inc. Questions

The BiOptic, Inc. annual revenue was $7.7 million in 2026.

Allen Chi is the Executive Vice President of BiOptic, Inc..

23 people are employed at BiOptic, Inc..

The NAICS codes for BiOptic, Inc. are [33, 334].

The SIC codes for BiOptic, Inc. are [382, 38].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users